Your browser doesn't support javascript.
loading
Effectiveness of remdesivir-based therapy for moderate COVID-19: comparison of Omicron and other variant phases.
Suzuki, Atsushi; Fukumitsu, Kensuke; Fukihara, Jun; Katano, Takuma; Kako, Hisashi; Maeda, Yuri; Ishii, Makoto; Niimi, Akio; Imaizumi, Kazuyoshi; Yamaguchi, Etsuro.
Afiliação
  • Suzuki A; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
  • Fukumitsu K; Department of Internal Medicine, Aichi Prefectural Hospital, Okazaki, Aichi, Japan.
  • Fukihara J; Department of Internal Medicine, Aichi Prefectural Hospital, Okazaki, Aichi, Japan.
  • Katano T; Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Kako H; Department of Internal Medicine, Aichi Prefectural Hospital, Okazaki, Aichi, Japan.
  • Maeda Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan.
  • Ishii M; Department of Internal Medicine, Aichi Prefectural Hospital, Okazaki, Aichi, Japan.
  • Niimi A; Department of Respiratory Medicine and Allergology, Aichi Medical University, Nagakute, Aichi, Japan.
  • Imaizumi K; Department of Internal Medicine, Aichi Prefectural Hospital, Okazaki, Aichi, Japan.
  • Yamaguchi E; Department of Respiratory Medicine, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
J Chemother ; 36(2): 127-132, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38044564

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Monofosfato de Adenosina / Alanina / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Monofosfato de Adenosina / Alanina / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article